{"id":"https://openalex.org/W1987538170","doi":"https://doi.org/10.1111/j.1463-1326.2010.01356.x","title":"Liraglutide, a once\u2010daily human glucagon\u2010like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes","display_name":"Liraglutide, a once\u2010daily human glucagon\u2010like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes","publication_year":2010,"publication_date":"2010-12-22","ids":{"openalex":"https://openalex.org/W1987538170","doi":"https://doi.org/10.1111/j.1463-1326.2010.01356.x","mag":"1987538170","pmid":"https://pubmed.ncbi.nlm.nih.gov/21205128","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3084519"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2010.01356.x","doi":"https://doi.org/10.1111/j.1463-1326.2010.01356.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2010.01356.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2010.01356.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2010.01356.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111569181","display_name":"Alan J. Garber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A. Garber","raw_affiliation_strings":["Department of Medicine and the Division of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, 1709 Dryden Road, Houston, TX 77030, USA. agarber@bcm.tmc.edu","Department of Medicine and the Division of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and the Division of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, 1709 Dryden Road, Houston, TX 77030, USA. agarber@bcm.tmc.edu","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Department of Medicine and the Division of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045462483","display_name":"Robert R. Henry","orcid":"https://orcid.org/0000-0002-4821-0117","observed_orcids":["https://orcid.org/0000-0002-4821-0117"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210099595","display_name":"VA San Diego Healthcare System","ror":"https://ror.org/00znqwq11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210099595","https://openalex.org/I4210138663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. R. Henry","raw_affiliation_strings":["Department of Medicine, University of California at San Diego, San Diego, CA, USA","Endocrinology and Metabolism, Veteran Affairs, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of California at San Diego, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Endocrinology and Metabolism, Veteran Affairs, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210099595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081205041","display_name":"Robert E. Ratner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405281094","display_name":"MedStar Health Research Institute","ror":"https://ror.org/03vny0n12","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405281094","https://openalex.org/I86755215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Ratner","raw_affiliation_strings":["MedStar Health Research Institute, Hyattsville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedStar Health Research Institute, Hyattsville, MD, USA","institution_ids":["https://openalex.org/I4405281094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023487929","display_name":"Paula M. Hale","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Hale","raw_affiliation_strings":["Novo Nordisk, Inc., Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk, Inc., Princeton, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039321628","display_name":"Cheng\u2010Chieh Chang","orcid":"https://orcid.org/0000-0002-9553-8342","observed_orcids":["https://orcid.org/0000-0002-9553-8342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. T. Chang","raw_affiliation_strings":["Novo Nordisk, Inc., Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk, Inc., Princeton, NJ, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005036709","display_name":"Bruce W. Bode","orcid":"https://orcid.org/0000-0002-9998-055X","observed_orcids":["https://orcid.org/0000-0002-9998-055X"]},"institutions":[{"id":"https://openalex.org/I4210107194","display_name":"Atlanta Diabetes Associates","ror":"https://ror.org/01j3vsz59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107194"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Bode","raw_affiliation_strings":["Atlanta Diabetes Associates, Atlanta, GA, USA","LEAD-3 Principal Investigators are listed in Appendix S1","Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta Diabetes Associates, Atlanta, GA, USA","institution_ids":["https://openalex.org/I4210107194"]},{"raw_affiliation_string":"LEAD-3 Principal Investigators are listed in Appendix S1","institution_ids":[]},{"raw_affiliation_string":"Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5111569181"],"corresponding_institution_ids":["https://openalex.org/I181547552"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":11.7157,"has_fulltext":true,"cited_by_count":195,"citation_normalized_percentile":{"value":0.99079817,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"13","issue":"4","first_page":"348","last_page":"356"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9440000057220459},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9769999980926514},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1-analog","display_name":"glucagon-like peptide-1 analogues","score":0.8429999947547913},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8799999952316284},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9160000085830688},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.703000009059906},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.8610000014305115},{"id":"https://openalex.org/keywords/long-term-monotherapy","display_name":"long-term monotherapy","score":0.6729999780654907},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.574999988079071},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.6669999957084656},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.4869999885559082},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8180000185966492},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9857769012451172},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.9477746486663818},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8216328620910645},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7556796073913574},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7009299993515015},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5433711409568787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5206286311149597},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4725368022918701},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4507378339767456},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.438912034034729},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4370206594467163},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.42677950859069824},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.40954431891441345},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40952008962631226},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3807348906993866},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3233415484428406},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.17583277821540833},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1463-1326.2010.01356.x","doi":"https://doi.org/10.1111/j.1463-1326.2010.01356.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2010.01356.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2010.01356.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2100169","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3084519","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3084519","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3084519","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:21205128","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21205128","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1111/j.1463-1326.2010.01356.x","doi":"https://doi.org/10.1111/j.1463-1326.2010.01356.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2010.01356.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2010.01356.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1987538170.pdf","grobid_xml":"https://content.openalex.org/works/W1987538170.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W43308025","https://openalex.org/W2011499650","https://openalex.org/W2024567427","https://openalex.org/W2071835038","https://openalex.org/W2081276121","https://openalex.org/W2098459806","https://openalex.org/W2113367996","https://openalex.org/W2137352234","https://openalex.org/W2138290933","https://openalex.org/W2160001758","https://openalex.org/W2170606300","https://openalex.org/W2337454357"],"related_works":["https://openalex.org/W2312778649","https://openalex.org/W2098459806","https://openalex.org/W2012425163","https://openalex.org/W2138290933","https://openalex.org/W1998281835","https://openalex.org/W2325198396","https://openalex.org/W1559082056","https://openalex.org/W1977119153","https://openalex.org/W2071835038","https://openalex.org/W3031548469"],"abstract_inverted_index":{"AIMS:":[0],"Most":[1],"treatments":[2],"for":[3,59,67,79,245],"type":[4],"2":[5,28,112,213,246],"diabetes":[6],"fail":[7],"over":[8,27],"time,":[9],"necessitating":[10],"combination":[11],"therapy.":[12],"We":[13],"investigated":[14],"the":[15,49,68,80,155],"safety,":[16],"tolerability":[17],"and":[18,74,84,102,106,138,180,199,210,233,250,256],"efficacy":[19,75],"of":[20,104,114,216,267],"liraglutide":[21,37,40,125,141,167,183,202,230],"monotherapy":[22,26,244],"compared":[23,236,259],"with":[24,120,124,140,162,166,182,229,237,260],"glimepiride":[25,44,121,163,238,261],"years.":[29],"METHODS:":[30],"Participants":[31,47],"were":[32,65,77,118,160,226],"randomized":[33],"to":[34,72,133,149,175,191],"receive":[35],"once-daily":[36],"1.2":[38,126,168,231],"mg,":[39],"1.8":[41,142,184,234],"mg":[42,127,143,169,185,232,235],"or":[43],"8":[45],"mg.":[46],"completing":[48,111],"1-year":[50],"randomized,":[51],"double-blind,":[52],"double-dummy":[53],"period":[54],"could":[55],"continue":[56],"open-label":[57],"treatment":[58],"an":[60],"additional":[61],"year.":[62],"Safety":[63],"data":[64,76],"evaluated":[66,78],"full":[69,81],"population":[70],"exposed":[71],"treatment,":[73],"intention-to-treat":[82],"(ITT)":[83],"2-year":[85],"completer":[86,200],"populations.":[87],"Outcome":[88],"measures":[89],"included":[90],"change":[91],"in":[92,206,253],"glycosylated":[93],"haemoglobin":[94],"(HbA1c),":[95],"fasting":[96],"plasma":[97,220],"glucose":[98,221],"(FPG),":[99],"body":[100,257],"weight":[101,258],"frequency":[103],"nausea":[105],"hypoglycaemia.":[107,268],"RESULTS:":[108],"For":[109,196],"patients":[110],"years":[113,247],"therapy,":[115],"HbA1c":[116,158],"reductions":[117,159],"-0.6%":[119,165],"versus":[122,164],"-0.9%":[123,181],"(difference:":[128,144,170,186],"-0.37,":[129],"95%":[130,146,172,188],"CI:":[131,147,173,189],"-0.71":[132],"-0.02;":[134],"p":[135,151,177,193],"=":[136,152,178],"0.0376)":[137],"-1.1%":[139],"-0.55,":[145],"-0.88":[148],"-0.21;":[150],"0.0016).":[153],"In":[154],"ITT":[156,198],"population,":[157],"-0.3%":[161],"-0.31,":[171],"-0.54":[174],"-0.08;":[176],"0.0076)":[179],"-0.60,":[187],"-0.83":[190],"-0.38;":[192],"<":[194,240],"0.0001).":[195,241],"both":[197],"populations,":[201],"was":[203],"more":[204],"effective":[205],"reducing":[207],"HbA1c,":[208],"FPG":[209],"weight.":[211],"Over":[212],"years,":[214],"rates":[215],"minor":[217],"hypoglycaemia":[218],"[self-treated":[219],"<3.1":[222],"mmol/l":[223],"(<56":[224],"mg/dl)]":[225],"significantly":[227],"lower":[228,265],"(p":[239],"CONCLUSION:":[242],"Liraglutide":[243],"provides":[248],"significant":[249],"sustained":[251],"improvements":[252],"glycaemic":[254],"control":[255],"monotherapy,":[262],"at":[263],"a":[264],"risk":[266]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":22},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":26},{"year":2013,"cited_by_count":19},{"year":2012,"cited_by_count":22}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}